Xiaoping Zhou Selected Research

Xiaoping Zhou Research Topics

Disease

18	Neoplasms (Cancer) 03/2024 - 02/2012
8	Breast Neoplasms (Breast Cancer) 04/2021 - 01/2014
4	Parkinson Disease (Parkinson's Disease) 01/2017 - 06/2012
4	Glioma (Gliomas) 02/2015 - 10/2004
3	Inflammation (Inflammations) 12/2022 - 01/2016
3	Pain (Aches) 01/2022 - 11/2014
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 08/2013
3	Neuralgia (Stump Neuralgia) 11/2014 - 01/2008
3	Infections 01/2010 - 11/2003
2	Lymphoma (Lymphomas) 01/2020 - 11/2016
2	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2019
2	Glioblastoma (Glioblastoma Multiforme) 12/2013 - 02/2012
1	Hypersensitivity (Allergy) 12/2023
1	Acute Lung Injury 10/2023
1	Osteoporosis 01/2023
1	Abscess 01/2023
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2023
1	Corneal Neovascularization 12/2022
1	Hydrocephalus (Hydrocephaly) 01/2022
1	Polyps 01/2022
1	Meibomian Gland Dysfunction 01/2022
1	Frailty 01/2022
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2022
1	Limbal Stem Cell Deficiency 01/2021
1	Postoperative Pain 01/2021
1	Corneal Endothelial Cell Loss 01/2021
1	Intracranial Hypertension 01/2021
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Atrophy 01/2021
1	Cardiotoxicity 01/2021
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021
1	Atherosclerosis 01/2021
1	Retinoblastoma (Glioblastoma, Retinal) 10/2020
1	Bacterial Infections (Bacterial Infection) 05/2020
1	Cognitive Dysfunction 01/2020

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 12/2022 - 08/2013
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2012
3	Tamoxifen FDA LinkGeneric 04/2021 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 05/2020
2	LigandsIBA 01/2022 - 01/2020
2	Estrogen ReceptorsIBA 01/2021 - 01/2020
2	Long Noncoding RNAIBA 01/2021 - 10/2020
2	CytokinesIBA 01/2021 - 01/2016
2	Analgesics (Analgesic Drugs)IBA 01/2021 - 01/2008
2	Glucose (Dextrose)FDA LinkGeneric 05/2019 - 09/2013
2	NAD (NADH)IBA 05/2019 - 03/2014
2	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 10/2004
2	Phosphotransferases (Kinase)IBA 01/2017 - 12/2015
2	Recombinant ProteinsIBA 10/2016 - 01/2016
2	LeptinIBA 01/2014 - 02/2012
2	Leptin ReceptorsIBA 01/2014 - 12/2013
2	TensinsIBA 08/2013 - 10/2004
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 08/2013 - 10/2004
1	AnthraquinonesIBA 03/2024
1	Carbonic Anhydrase IXIBA 03/2024
1	BenzenesulfonamidesIBA 03/2024
1	Carbonic Anhydrase InhibitorsIBA 03/2024
1	Carbonic Anhydrase IIIBA 03/2024
1	Protein Isoforms (Isoforms)IBA 03/2024
1	Messenger RNA (mRNA)IBA 01/2024
1	Dermal FillersIBA 12/2023
1	LipopolysaccharidesIBA 10/2023
1	SodiumIBA 10/2023
1	sivelestatIBA 10/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	ChemokinesIBA 01/2022
1	Hypochlorous Acid (Hypochlorite)IBA 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	ChitinasesIBA 01/2022
1	teleocalcinIBA 01/2022
1	Calcibiotic Root Canal SealerIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	HMGB1 Protein (HMG1)IBA 04/2021
1	Hormones (Hormone)IBA 04/2021
1	Interleukin-18 (Interleukin 18)IBA 01/2021
1	Sodium-Glucose Transporter 1IBA 01/2021
1	AnthracyclinesIBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	InflammasomesIBA 01/2021
1	SolutionsIBA 01/2021
1	Sodium-Glucose Transport ProteinsIBA 01/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	Bee Venoms (Bee Venom)IBA 01/2021
1	MTOR InhibitorsIBA 12/2020
1	Formaldehyde (Formol)FDA Link 11/2020
1	ParaffinIBA 11/2020
1	CC ChemokinesIBA 01/2020
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2020

Therapy/Procedure

7	Therapeutics 04/2021 - 10/2004
2	Activities of Daily Living (ADL) 01/2023 - 01/2022
2	Drug Therapy (Chemotherapy) 01/2021 - 12/2013
2	Ligation 11/2014 - 01/2008
2	Deep Brain Stimulation 05/2013 - 06/2012
1	Craniotomy 01/2023
1	Polypharmacy 01/2022
1	Decompression 01/2022
1	Ventriculoperitoneal Shunt 01/2022
1	Decompressive Craniectomy 01/2021
1	Transplantation 01/2021